Status epilepticus caused by a myxoedema coma

Netherlands Journal of Medicine

Volumn 64, Issue 6, 2006, Pages 202-205

  Jansen, Henry J ^a,b   Oedit Doebe S R ^a   Louwerse, E S ^a   van der Linden, J C ^a   Netten, P M ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Myxoedema coma; Severe hypothyroidism; Status epilepticus

Indexed keywords

CEFUROXIME; DIAZEPAM; HYDROCORTISONE; LIOTHYRONINE; PHENYTOIN; THIOPENTAL; THYROXINE;

ADULT; ARTICLE; ATAXIA; CASE REPORT; COMA; CONCENTRATION LOSS; CRANIAL NERVE PARALYSIS; DIAGNOSTIC PROCEDURE; DISEASE SEVERITY; DYSARTHRIA; EPILEPTIC STATE; FEMALE; HEADACHE; HOARSENESS; HUMAN; HYPOTHERMIA; HYPOTHYROIDISM; HYPOVENTILATION; LETHARGY; MENTAL DISEASE; MORTALITY; MYOPATHY; MYXEDEMA; NEUROLOGIC DISEASE; NEUROPATHY; PSYCHOSIS; REFLEX DISORDER; VENTILATOR ASSOCIATED PNEUMONIA;

ATROPHY; COMA; FATAL OUTCOME; FEMALE; GLASGOW COMA SCALE; HUMANS; HYPOTHYROIDISM; MIDDLE AGED; MYXEDEMA; RESPIRATORY TRACT DISEASES; STATUS EPILEPTICUS; THYROID GLAND; THYROXINE;

EID: 33745660994     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia 1999;40:S3-8.
2. Fliers E, Wiersinga WM. Myxedema coma. Rev Endo Metab Disord 2003;4:137-41.
3. Woods KL, Holmes GKT. Myxedema coma presenting in status epilepticus. Postgrad Med J 1977;53:46-8.
4. Jordan RM. Myxedema coma: Pathophysiology, therapy and factors affecting prognosis. Med Clin North Am 1995;79:185-94.
5. Nicoloff JT, LoPresti JS. Myxedema coma. A form of decompensated hypothyroidism. Endocrinol Metab Clin North Am 1993;22:279-90.
6. Evans EC. Neurological complications of myxedema: convulsions. Ann Int Med 1960;52:434-44.
7. Jellinek EH. Fits, faints, coma and dementia in myxoedema. Lancet 1962;2:1010-12.
8. Levin ME, Daughaday WH. Fatal coma due to myxedema. Am J Med 1955;18:1017-21.
9. Nielsen PE, Ranløv P. Myxedema coma. Two case-reports and a review. Acts Endocrinologica 1964;45:353-64.
10. Lansing RW, Trunnel JB. Electroencephalographic changes accompanying thyroid deficiency in man. J Clin Endocrinol Metab 1963;23:470-80.
11. Hylander B, Rosenqvist U. Treatment of myxedema coma - factors associated with fatal outcome. Acta Endocrinol (Copenhagen) 1985;108:65-71.
12. Holvey DN, Goodner CJ, Dowling JT, et al. Treatment of myxedema coma with intravenous thyroxin. Arch Intern Med 1964;113:139-46.
13. Iwasaki Y, Oisa Y, Yamauchi K, et al. Osmoregulation of plasma vasopressin in myxedema. J Clin Endocrinol Metab 1990;70:534-39.
14. Arlot S, Debussche X, Lalau JD, et al. Myxoedema coma: response of thyroid hormones with oral and intravenous high-dose L-thyroxin treatment. Intensive Care Med 1991;17:16-8.
15. Rodriguez I, Fluiters E, Pérez-Méndez, et al. Factors associated with mortality of patients with myxedema coma: prospective study in 11 cases treated in a single institution. J Endocrinol 2004; 180:347-50.